1. GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice
   Natasha Friend et al, 2020, PLOS ONE CrossRef
2. Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index
   Yongjie Wang et al, 2024, Clinical and Translational Medicine CrossRef
3. miRNA signatures in childhood sarcomas and their clinical implications
   G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef
4. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression
   Yu Liu et al, 2019, Biochemical and Biophysical Research Communications CrossRef
5. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients
   Marios A. Diamantopoulos et al, 2017, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef
6. Expression and Genetic Effects of GLI Pathogenesis-Related 1 Gene on Backfat Thickness in Pigs
   Xin Liu et al, 2022, Genes CrossRef
7. GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivo
   Urban J. Scheuring et al, 2021, Journal of Neuro-Oncology CrossRef
8. GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway
   Yuen Chak Tiu et al, 2022, Cancer Gene Therapy CrossRef
9. The PR-1 domain accounts for the anti-angiogenic activity of a cysteine-rich secretory protein member from the buccal glands of Lampetra japonica
   Dandan Duan et al, 2018, International Journal of Biological Macromolecules CrossRef
10. Advances in differentiation therapy for osteosarcoma
    Yingqian Chen et al, 2020, Drug Discovery Today CrossRef
11. Glioma pathogenesis-related protein 1 performs dual functions in tumor cells
    Junjie Wang et al, 2022, Cancer Gene Therapy CrossRef